Related Experiment Video
Updated: Aug 6, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Development of An Explainable Machine Learning Model for Predicting Fatigue in Rheumatoid Arthritis
Yucao Ma1, Yiyan Zhang2, Yunxi He2
1Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Combinatorial Chemistry & High Throughput Screening
|July 20, 2026
Summary
Machine learning models show promise in predicting rheumatoid arthritis (RA) fatigue using clinical data. The Support Vector Machine (SVM) model identified patients at risk, though further validation is needed.
Area of Science:
- Rheumatology
- Medical Informatics
- Machine Learning
Background:
- Fatigue is a prevalent symptom in rheumatoid arthritis (RA), significantly impacting patient quality of life.
- Few predictive models exist for RA-related fatigue using clinical indicators.
- This study explores machine learning (ML) for developing such predictive models.
Purpose of the Study:
- To develop and evaluate machine learning models for predicting fatigue in rheumatoid arthritis (RA) patients.
- To identify key clinical predictors of RA-related fatigue.
Main Methods:
- Retrospective analysis of clinical data from 271 RA patients.
- Feature selection using Lasso, Boruta, and RF-RFE algorithms.
- Development and evaluation of ML models including SVM, XGBoost, LightGBM, ANN, KNN, and RF, with external validation.
Main Results:
- Six key predictors identified: CCP, ESR, lymphocyte count, MDGA, VAS for pain, and TG.
- ML models, particularly SVM, XGBoost, and Random Forest, demonstrated superior predictive performance compared to logistic regression in external validation.
- The SVM model showed potential in identifying RA patients at risk of fatigue.
Conclusions:
- Machine learning models can capture complex relationships between clinical variables for fatigue prediction in RA.
- The developed SVM model shows potential for identifying RA patients at risk of fatigue.
- Results are preliminary, requiring validation in larger, multicenter studies.
